CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Option exercise | +9,450 | 44,731 | ||
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −2,693 | $1.23 | $3K | 42,038 |
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −9,450 | 18,900 | ||
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +46,876 | 46,876 | ||
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +37,684 | 37,684 | ||
| 2026-05-15 | Sumner Michael John Chief Medical Officer | Option exercise | +2,385 | 35,961 | ||
| 2026-05-15 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −680 | $1.30 | $884 | 35,281 |
| 2026-05-15 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,385 | 0 | ||
| 2026-03-31 | Sumner Michael John Chief Medical Officer | Option exercise | +4,292 | 34,799 | ||
| 2026-03-31 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −1,223 | $1.74 | $2K | 33,576 |
| 2026-03-31 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −4,292 | 0 | ||
| 2026-03-04 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +36,832 | 36,832 | ||
| 2026-03-04 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +29,608 | 29,608 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise | +5,010 | 22,860 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise | +11,550 | 34,410 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −3,903 | $1.79 | $7K | 30,507 |
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −5,010 | 5,009 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −11,550 | 23,100 | ||
| 2025-06-30 | Sumner Michael John Chief Medical Officer | Option exercise | +2,916 | 17,850 | ||
| 2025-06-30 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,916 | 0 |
Page 1 of 3 · 43 trades